Study to Assess MEDI -578 in Patients With Osteoarthritis (OA) of the Knee
Status:
Terminated
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of a single intravenous
dose of MEDI-578, a monoclonal antibody, in patients with osteoarthritis of the knee. It will
also be evaluated how MEDI-578 is absorbed and distributed through the body.